John H. Weiland
Columbus Home Medical Equipment
John H. Weiland joined C. R. Bard, Inc. on March 1, 1996. His experience spans over 30 years in the healthcare industry with firms such as Dentsply International, Pharmacia and Baxter Healthcare Corporation. John was elected to the Board of Directors in April 2005 and assumed the title of Vice Chairman in August 2016. John was named President and Chief Operating Officer of C. R. Bard on August 8, 2003, having worldwide responsibility for all of Bard's business operations. Prior to becoming President and COO, John held the position of Group President of Bard. In this capacity, John had global responsibility for Bard Medical Division, Bard Urological Division, Davol Inc., Bard Endoscopic Technologies Division, Bard Access Systems, Bard Peripheral Vascular, and Bard's Worldwide Manufacturing Operations. In 1991, he was named Senior Vice President North America Group for Dentsply International in York, Pennsylvania. This position included general management responsibility for the eleven operating divisions of Dentsply International, the world's leading dental products manufacturer. John graduated from DeSales University with a B.S. degree and earned an M.B.A. degree from New York University. John started his career at Baxter/American Hospital Supply Corporation in 1977 as a sales representative. He rose through numerous managerial positions to become Vice President and General Manager of the Scientific Products Biomedical Division, an 850 million dollar diagnostic division of Baxter. In 1989, he became President and Chief Executive Officer of Pharmacia Diagnostics, a division of Pharmacia AB Uppsala Sweden. In this capacity, he had general management responsibility for Pharmacia's three diagnostic businesses. In addition to his professional activities, John is actively involved in civic affairs. In 1987, John was named a White House Fellow and served as a Special Assistant to two members of President Reagan's Cabinet. In 2012, he was a recipient of the prestigious Horatio Alger Award. He is also a director of West Pharmaceutical Services, Inc.
Bioengineering & Biomedical science